> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# 3 Observations in Dr. Reddy’s Lab Inspection
- URL: https://www.fdaweb.com/3-observations-in-dr-reddys-lab-inspection/
- Published: 2024-01-03T12:00:00.000Z
- Updated: 2026-09-14T14:19:32.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5156061

FDA has released the form FDA-483 issued following a 12/4-12/8/2023 inspection at the Dr. Reddy’s Laboratories drug testing establishment in Telangana, India. The three inspection observations were:

- laboratory records are deficient in that they do not include a complete record of all data obtained during testing;
- determinations of conformance to appropriate written specifications for acceptance are deficient for drug products; and
- employees are not given training in the particular operations they perform as part of their function and current good manufacturing practices.